NCT06689930 Community-based Implementation of Adapted STAC
| NCT ID | NCT06689930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-05-22 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-05-22 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to adapt the Staying Healthy After Childbirth (STAC) intervention for implementation among Black Women and Birthing Persons (WBP).
Eligibility Criteria
Inclusion Criteria (Interviews and Focus Groups): * Belong to the STAC-CAB or Lived Experience Group * Aged 18 or older Inclusion Criteria (CBO Staff): * Staff of CBO participating in PDSA cycle * Aged 18 years or older Inclusion Criteria (PDSA-Cycles): * Pregnant persons greater than or equal to 24 weeks gestation and prior to delivery or postpartum * Self-Identify as African American or Black * Aged 18 years or older * Capable of providing informed consent in English * Can follow M•care System use instructions in English * Have ownership of a functioning and reliable smartphone to upload and use the M•other App * Interested in preventing or managing blood pressure during pregnancy Exclusion Criteria (PDSA-Cycles): * Persistent second or third trimester bleeding at time of enrollment * Premature rupture of membranes in the current pregnancy at time of enrollment * Known unrepaired maternal congenital heart disease requiring surgical correction * Maternal heart failure * Chronic kidney disease specifically requiring dialysis * On greater than two antihypertensive medications at time of enrollment
Contact & Investigator
Kara Hoppe, DO, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06689930 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06689930 currently recruiting?
Yes, NCT06689930 is actively recruiting participants. Contact the research team at prccoreproject_obgyn@wisc.edu for enrollment information.
Where is the NCT06689930 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06689930 clinical trial?
NCT06689930 is sponsored by University of Wisconsin, Madison. The principal investigator is Kara Hoppe, DO, PhD at University of Wisconsin, Madison. The trial plans to enroll 46 participants.